5. References
- Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc; 2024. Available at: http://www.clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu. Accessed April 14, 2024.
- Aspirin low dose tablets product information. Bayer Healthcare LLC. November 2011.
- Aspirin enteric coated tablets product information. Bayer Healthcare LLC. November 2023.
- Aspirin extra strength caplets product information. Bayer Healthcare LLC. November 2023.
- Diclofenac potassium powder for solution (Cambia) package insert. Assertio Therapeutics, Inc. April 2024.
- Diclofenac potassium tablet (Lofena) package insert. Carwin Pharmaceutical Associates, LLC. January 2024.
- Diclofenac potassium tablets package insert. Umedica Labratories, December 2023.
- Diclofenac potassium liquid filled capsule (Zipsor) package insert. Assertio Therapeutics, Inc. April 2021.
- Diclofenac epolamine patch (Flector) package insert. IBSA Pharma Inc. April 2021.
- Diclofenac epolamine patch (Licart) package insert. IBSA Pharma Inc. December 2023.
- Diclofenac sodium gel (Voltaren) product information. Haleon US Holdings LLC. March 2024.
- Diflunisal oral tablet package insert. Chartwell RX, LLC. February 2023.
- Etodolac tablets and capsules package insert. Taro Pharmaceuticals U.S.A., Inc. March 2021.
- Etodolac extended-release tablets package insert. Northstar RX LLC. May 2021.
- Fenoprofen calcium oral capsule (Nalfon) package insert. Xspire Pharma. October 2023.
- Fenoprofen calcium oral tablet (Nalfon) package insert. Xspire Pharma. October 2023.
- Flurbiprofen oral tablet package insert. Bryant Ranch Prepack. November 2023.
- Ibuprofen sodium tablets (Advil) product information. Haleon US Holdings, LLC. April 2024
- Ibuprofen capsules (Advil) product information. Haleon US Holdings, LLC. April 2024.
- Ibuprofen oral tablets (Motrin) product information. Johnson & Johnson Consumer, Inc. March 2023.
- Ibuprofen oral capsules (Motrin) product information. Johnson & Johnson Consumer, Inc. March 2023.
- Indomethacin oral capsule package insert. Chartwell RX, LLC. October 2023.
- Indomethacin extended release capsules package insert. KVK-Tech, Inc. February 2024.
- Indomethacin suppository (Indocin) package insert. Zyla Life Sciences US Inc. July 2023.
- Ketoprofen oral capsule package insert. Misemer Pharmaceuticals, Inc. February 2024.
- Ketoprofen extended release oral capsule package insert. Mylan Pharmaceuticals Inc. March 2021.
- Ketorolac tromethamine oral tablets package insert. Camber Pharmaceuticals, Inc., October 2022.
- Magnesium salicylate oral tablets (Doan’s Extra Strength) product information. Dr. Reddy’s Laboratories, Inc. June 2016.
- Meclofenamate oral capsule package insert. Mylan Pharmaceuticals Inc. May 2021.
- Mefenamic acid capsules package insert. Belcher Pharmaceuticals, LLC. October 2023.
- Meloxicam oral tablets package insert. AiPing Pharmaceuticals, Inc. May 2024.
- Meloxicam oral suspension package insert. Avondale Pharmaceuticals, LLC. April 2022.
- Meloxicam capsules package insert. Lupin Pharmaceuticals, Inc. November 2023.
- Nabumetone oral tablet package insert. LGM Pharma Solutions, LLC. January 2024.
- Nabumetone oral tablets (Relafen DS) package insert. Carwin Pharmaceutical Associates, LLC. January 2024.
- Naproxen sodium oral tablets (Aleve) product information. Bayer HealthCare LLC. October 2022.
- Naproxen delayed-release tablets (EC-Naprosyn), naproxen tablets (Naprosyn), naproxen sodium tablets (Anaprox/Anaprox DS) package insert. Canton Laboratories. April 2021.
- Naproxen sodium controlled-release tablets (Naprelan) package insert. Almatica Pharma. April 2023.
- Oxaprozin caplets (Daypro) package insert. Pfizer. November 2022.
- Oxaprozin oral capsules (Coxanto) package insert. Solubiomic, LLC. September 2023.
- Piroxicam oral capsules (Feldene) package insert. Pfizer. May 2024.
- Salsalate oral tablets package insert. Amneal Pharmaceuticals, LLC. December 2023.
- Sulindac oral tablet package insert. Actavis Pharma, Inc. May 2023.
- Acetaminophen, aspirin, and caffeine oral tablets (Excedrin) product information. Lil Drug Store Products, Inc. October 2023.
- Acetaminophen, aspirin, and caffeine oral powder (Goody’s) product information. April 2020.
- Butalbital, aspirin, and caffeine oral capsule package insert. Chartwell RX, LLC. October 2023.
- Diclofenac sodium/misoprostol tablets (Arthrotec) package insert. Pfizer. August 2023.
- Ibuprofen and famotidine oral tablet (Duexis) package insert. Horizon Therapeutics USA, Inc. August 2023.
- Naproxen and esomeprazole magnesium oral tablet (Vimovo) package insert. Horizon Therapeutics USA, Inc. July 2023.
- Ibuprofen oral suspension/ drops (Infant’s Motrin) product information. Johnson & Johnson Consumer, Inc. March 2023.
- Ibuprofen oral suspension (100 mg/5 ml) (Children’s Motrin) product information. Johnson & Johnson Consumer, Inc. March 2023.
- Diclofenac sodium 3% gel package insert. Bryant Ranch Prepack. July 2023.
- Wongrakpanich S, Wongrakpanich A, Melhado K, Rangaswami J. A comprehensive review of non-steroidal anti-inflammatory drug use in the elderly. Aging Dis. 2018;9(1):143-150.
- United States Food and Drug Administration. FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes. (July 9, 2015) Available at: http://www.fda.gov/Drugs/DrugSafety/ucm451800.htm. Accessed June 20, 2022.
- Friedewald VE, Bennett JS, Christo JP, et al. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010;106(6):873-84.
- U.S. Food and Drug Administration. Center for Drug Evaluation and Research. COX-2 selective (includes Bextra, Celebrex, and Vioxx) and non-selective non-steroidal anti-inflammatory drugs (NSAIDs). (February 6, 2018) Available at: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/cox-2-selective-includes-bextra-celebrex-and-vioxx-and-non-selective-non-steroidal-anti-inflammatory. Accessed June 20, 2022.
- Waksman JC, Brody A, Phillips SD. Nonselective nonsteroidal antiinflammatory drugs and cardiovascular risk: are they safe? Ann Pharmacother. 2007;41:1163-73.
- Spence JD, Grosser T, Fitzgerald GA. Acetaminophen, nonsteroidal anti-inflammatory drugs, and hypertension. Hypertension. 2022;79:1922-1926.
- Lazzaroni M, Battocchia A, Porro GB. COXIBs and non-selective NSAIDs in the gastroenterological setting: What should patients and physicians do? Dig Liver Dis. 2007;39:589-96.
- Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis. The CLASS study: a randomized trial. JAMA. 2000;284;1247-55.